248 related articles for article (PubMed ID: 20180779)
21. Insights into an efficient light-driven hybrid P450 BM3 enzyme from crystallographic, spectroscopic and biochemical studies.
Spradlin J; Lee D; Mahadevan S; Mahomed M; Tang L; Lam Q; Colbert A; Shafaat OS; Goodin D; Kloos M; Kato M; Cheruzel LE
Biochim Biophys Acta; 2016 Dec; 1864(12):1732-1738. PubMed ID: 27639964
[TBL] [Abstract][Full Text] [Related]
22. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
23. Insights into electron leakage in the reaction cycle of cytochrome P450 BM3 revealed by kinetic modeling and mutagenesis.
Lim JB; Barker KA; Eller KA; Jiang L; Molina V; Saifee JF; Sikes HD
Protein Sci; 2015 Nov; 24(11):1874-83. PubMed ID: 26311413
[TBL] [Abstract][Full Text] [Related]
24. Control of the stereo-selectivity of styrene epoxidation by cytochrome P450 BM3 using structure-based mutagenesis.
Huang WC; Cullis PM; Raven EL; Roberts GC
Metallomics; 2011 Apr; 3(4):410-6. PubMed ID: 21240430
[TBL] [Abstract][Full Text] [Related]
25. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
Joyce MG; Girvan HM; Munro AW; Leys D
J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the oxidation of short chain alkynes by flavocytochrome P450 BM3.
Waltham TN; Girvan HM; Butler CF; Rigby SR; Dunford AJ; Holt RA; Munro AW
Metallomics; 2011 Apr; 3(4):369-78. PubMed ID: 21431175
[TBL] [Abstract][Full Text] [Related]
27. Human P450-like oxidation of diverse proton pump inhibitor drugs by 'gatekeeper' mutants of flavocytochrome P450 BM3.
Butler CF; Peet C; McLean KJ; Baynham MT; Blankley RT; Fisher K; Rigby SE; Leys D; Voice MW; Munro AW
Biochem J; 2014 Jun; 460(2):247-59. PubMed ID: 24588219
[TBL] [Abstract][Full Text] [Related]
28. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
29. 4-cyanopyridine, a versatile spectroscopic probe for cytochrome P450 BM3.
Ost TW; Clark JP; Anderson JL; Yellowlees LJ; Daff S; Chapman SK
J Biol Chem; 2004 Nov; 279(47):48876-82. PubMed ID: 15364917
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Monomeric and Dimeric Structures of CYP102A1 Using AlphaFold2 and AlphaFold Multimer and Assessment of Point Mutation Effect on the Efficiency of Intra- and Interprotein Electron Transfer.
Ivanov YD; Taldaev A; Lisitsa AV; Ponomarenko EA; Archakov AI
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209175
[TBL] [Abstract][Full Text] [Related]
31. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
32. Process intensification for cytochrome P450 BM3-catalyzed oxy-functionalization of dodecanoic acid.
Buergler MB; Dennig A; Nidetzky B
Biotechnol Bioeng; 2020 Aug; 117(8):2377-2388. PubMed ID: 32369187
[TBL] [Abstract][Full Text] [Related]
33. An efficient light-driven P450 BM3 biocatalyst.
Tran NH; Nguyen D; Dwaraknath S; Mahadevan S; Chavez G; Nguyen A; Dao T; Mullen S; Nguyen TA; Cheruzel LE
J Am Chem Soc; 2013 Oct; 135(39):14484-7. PubMed ID: 24040992
[TBL] [Abstract][Full Text] [Related]
34. Probing the molecular determinants of coenzyme selectivity in the P450 BM3 FAD/NADPH domain.
Dunford AJ; Girvan HM; Scrutton NS; Munro AW
Biochim Biophys Acta; 2009 Aug; 1794(8):1181-9. PubMed ID: 19344791
[TBL] [Abstract][Full Text] [Related]
35. The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.
de Beer SB; van Bergen LA; Keijzer K; Rea V; Venkataraman H; Guerra CF; Bickelhaupt FM; Vermeulen NP; Commandeur JN; Geerke DP
Curr Drug Metab; 2012 Feb; 13(2):155-66. PubMed ID: 22208530
[TBL] [Abstract][Full Text] [Related]
36. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
37. Structural and spectroscopic analysis of the F393H mutant of flavocytochrome P450 BM3.
Ost TW; Munro AW; Mowat CG; Taylor PR; Pesseguiero A; Fulco AJ; Cho AK; Cheesman MA; Walkinshaw MD; Chapman SK
Biochemistry; 2001 Nov; 40(45):13430-8. PubMed ID: 11695889
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the properties of two single-site proline mutants of CYP102A1 (P450BM3).
Whitehouse CJ; Yang W; Yorke JA; Rowlatt BC; Strong AJ; Blanford CF; Bell SG; Bartlam M; Wong LL; Rao Z
Chembiochem; 2010 Dec; 11(18):2549-56. PubMed ID: 21110374
[TBL] [Abstract][Full Text] [Related]
39. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
40. Probing electron transfer in flavocytochrome P-450 BM3 and its component domains.
Munro AW; Daff S; Coggins JR; Lindsay JG; Chapman SK
Eur J Biochem; 1996 Jul; 239(2):403-9. PubMed ID: 8706747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]